Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 78110 38 0. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102127068B details a green synthesis route for Aztreonam using aqueous-alcoholic solvents, offering significant cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN106520857A reveals enzymatic deprotection for high-purity Aztreonam. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN101514200B details a novel aztreonam synthesis using active esters and mild deprotection, offering significant cost reduction in pharmaceutical manufacturing and improved supply chain reliability.
Novel three-step purification method for Aztreonam achieving over 99.5% purity. Reduces heavy metals and improves supply chain reliability for antibiotic manufacturing.
Novel synthetic route for Aztreonam using acetic acid and hydrochloric acid deprotection, offering high purity and scalable production for pharmaceutical intermediates.